If your healthcare provider has prescribed Navelbine (vinorelbine), you may receive a generic version of this drug. Numerous companies make generic Navelbine products, which are available in two different strengths. Although the generic Navelbine products are considered equivalent to the brand-name version, they may contain different inactive ingredients, such as fillers or dyes, than the brand-name drug.
Navelbine® (vinorelbine) is a prescription chemotherapy medication approved to treat a certain type of lung cancer. It belongs to a group of medicines known as vinca alkaloids.
Navelbine is made by Pierre Fabre Médicament for Pierre Fabre Pharmaceuticals, Inc. The medication is no longer protected by patents and is available as a generic.
Generic Navelbine is available in the following strengths:
- Vinorelbine 10 mg per mL
- Vinorelbine 50 mg per 5 mL.
Generic Navelbine is made by many different companies, including but not limited to:
- APP Pharmaceutical
- Bedford Laboratories
- Teva Pharmaceuticals.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating.
An "AP" rating means that the FDA has determined that a generic injectable medication is equivalent to a brand-name injectable medication. All of the generic Navelbine versions currently available have an "AP" rating, meaning they should be equivalent to Navelbine.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.